Associations between biomarkers of cellular senescence and physical function in humans: observations from the lifestyle interventions for elders (LIFE) study
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a plausible mediator of age-associated declines in physical performance. To test this premise, we examined cross-sectional associations between circulating components of the senescence-associated secretory phenotype (SASP) and measures of physical function and muscle strength in 1377 older adults. We showed significant associations between multiple SASP proteins and the short physical performance battery (SPPB), its subcomponents (gait speed, balance, chair rise time), and 400-m walk time. Activin A, ICAM1, MMP7, VEGFA, and eotaxin showed strong associations based on gradient boost machine learning (GBM), and, when combined with other proteins, effectively identified participants at the greatest risk for mobility disability (SPPB score $$\le$$ ≤ 7). Senescence biomarkers were also associated with lower grip strength, and GBM identified PARC, ADAMTS13, and RANTES as top candidates in females, and MMP2, SOST, and MCP1 in males. These findings highlight an association between senescence biomarkers and physical performance in older adults. ClinicalTrials.gov Identifier: NCT01072500.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent evidence suggests that the accumulation of senescent cells, which can release a variety of pro-inflammatory, apoptotic, and toxic by-products, called the senescence-associated secretory phenotype (SASP), is one of the drivers of deficits in both cognition11, 12, 13, 14, 15, 16 and mobility.7,17, 18, 19, 20, 21, 22”
From A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer's disease (2025) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 1×
“Importantly, poor performance on the SPPB and 400 m walk is associated with a heightened risk of disability, institutionalization, and mortality among older adults [2, 3, 16, 17].”
BackgroundGait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320902 · Cited by 4,083
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 1×
“Cellular senescence is a hallmark of aging [6, 7].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 14×
“The expression of ICAM1 is triggered by p53 and NFκB signaling and thus, it is a component of the SASP that we previously observed to be secreted by senescent endothelial and epithelial cells and preadipocytes [13].”
BackgroundInfluentialSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
Self-citationMidlife Hand Grip Strength as a Predictor of Old Age Disability
Rantanen, T. (1999) · JAMA · doi:10.1001/jama.281.6.558 · Cited by 1,476
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229 · cited 1×
“It is not surprising that circulating levels of ICAM1 have previously been associated with cardiovascular disease onset and progression [36].”
BackgroundGrip Strength across the Life Course: Normative Data from Twelve British Studies
Dodds, R. M., Syddall, H. E., Cooper, R., Benzeval, M., Deary, I. J., Dennison, E. M., Der, G., Gale, C. R., Inskip, H. M., Jagger, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113637 · Cited by 1,221
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Verstovsek, S., Kantarjian, H., Mesa, R. A., Pardanani, A. D., Cortes-Franco, J., Thomas, D. A., Estrov, Z., Fridman, J. S., Bradley, E. C., Erickson-Viitanen, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002028 · Cited by 1,164
Cellular senescence: a translational perspective
Kirkland, J. L., & Tchkonia, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.013 · Cited by 1,013 · cited 1×
“Through the SASP, comprised of cytokines, chemokines, matrix remodeling proteins, growth factors, and a host of other bioactive molecules, senescent cells mediate age-associated tissue inflammation, deterioration, and remodeling, and, simultaneously, compromise regeneration both locally and systemically [9].”
BackgroundNewman, A. B., Simonsick, E. M., Naydeck, B. L., Boudreau, R. M., Kritchevsky, S. B., Nevitt, M. C., Pahor, M., Satterfield, S., Brach, J. S., Studenski, S. A., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2018 · Cited by 934
Self-citationXu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915 · cited 2×
“Interestingly, in preclinical models, enrichment of the SASP through senescent cell transplantation compromises muscle performance and physical function [10], while pharmacological suppression of the SASP has been shown to improve these parameters [11, 12].”
BackgroundSelf-citationThe senescence-associated secretome as an indicator of age and medical risk
Schafer, M. J., Zhang, X., Kumar, A., Atkinson, E. J., Zhu, Y., Jachim, S., Mazula, D. L., Brown, A. K., Berning, M., Aversa, Z., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133668 · Cited by 401 · cited 5×
“The expression of ICAM1 is triggered by p53 and NFκB signaling and thus, it is a component of the SASP that we previously observed to be secreted by senescent endothelial and epithelial cells and preadipocytes [13].”
BackgroundMethodInfluentialSelf-citationVasunilashorn, S., Coppin, A. K., Patel, K. V., Lauretani, F., Ferrucci, L., Bandinelli, S., & Guralnik, J. M. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln022 · Cited by 381
Global variation in grip strength: a systematic review and meta-analysis of normative data
Dodds, R. M., Syddall, H. E., Cooper, R., Kuh, D., Cooper, C., & Sayer, A. A. (2016) · Age and Ageing · doi:10.1093/ageing/afv192 · Cited by 372
Kuh, D., Bassey, E. J., Butterworth, S., Hardy, R., Wadsworth, M. E. J., & and the Musculoskeletal Study Team (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.2.224 · Cited by 351
Onder, G., Penninx, B. W. J. H., Ferrucci, L., Fried, L. P., Guralnik, J. M., & Pahor, M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.1.74 · Cited by 347
Self-citationMaximal Isometric Strength and Mobility among 75-year-old Men and Women
RANTANEN, T., ERA, P., & HEIKKINEN, E. (1994) · Age and Ageing · doi:10.1093/ageing/23.2.132 · Cited by 300
Ability to Walk 1/4 Mile Predicts Subsequent Disability, Mortality, and Health Care Costs
Hardy, S. E., Kang, Y., Studenski, S. A., & Degenholtz, H. B. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1543-2 · Cited by 280 · cited 1×
“Importantly, poor performance on the SPPB and 400 m walk is associated with a heightened risk of disability, institutionalization, and mortality among older adults [2, 3, 16, 17].”
BackgroundThe Lifestyle Interventions and Independence for Elders Study: Design and Methods
Fielding, R. A., Rejeski, W. J., Blair, S., Church, T., Espeland, M. A., Gill, T. M., Guralnik, J. M., Hsu, F.-C., Katula, J., King, A. C., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr123 · Cited by 278
Self-citationPutative Cut‐Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis
Cawthon, P. M., Manini, T., Patel, S. M., Newman, A., Travison, T., Kiel, D. P., Santanasto, A. J., Ensrud, K. E., Xue, Q., Shardell, M., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16517 · Cited by 231 · cited 1×
“, muscle weakness), which is associated with increased risk for mobility limitations and mortality in both sexes [5, 28].”
BackgroundSelf-citationQuantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease
Schafer, M. J., Atkinson, E. J., Vanderboom, P. M., Kotajarvi, B., White, T. A., Moore, M. M., Bruce, C. J., Greason, K. L., Suri, R. M., Khosla, S., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.023 · Cited by 206
Self-citationCharacterization of cellular senescence in aging skeletal muscle
Zhang, X., Habiballa, L., Aversa, Z., Ng, Y. E., Sakamoto, A. E., Englund, D. A., Pearsall, V. M., White, T. A., Robinson, M. M., Rivas, D. A., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00250-8 · Cited by 206 · cited 1×
“Finally, we have recently identified distinct subpopulations of fibroadipogenic progenitors and postmitotic myofibers that are localized in aging skeletal muscle and express features of cellular senescence [33].”
BackgroundSelf-citationActivin A more prominently regulates muscle mass in primates than does GDF8
Latres, E., Mastaitis, J., Fury, W., Miloscio, L., Trejos, J., Pangilinan, J., Okamoto, H., Cavino, K., Na, E., Papatheodorou, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15153 · Cited by 185 · cited 1×
“Antibody-based inhibition of circulating activin A results in significant increases in muscle growth and force in mice and lean mass in cynomolgus monkeys [34].”
BackgroundCellular Senescence and the Biology of Aging, Disease, and Frailty
LeBrasseur, N. K., Tchkonia, T., & Kirkland, J. L. (2015) · Nestlé Nutrition Institute Workshop Series · doi:10.1159/000382054 · Cited by 147 · cited 1×
“Cellular senescence is a hallmark of aging [6, 7].”
BackgroundSelf-citationDevelopmental Origins of Midlife Grip Strength: Findings From a Birth Cohort Study
Kuh, D., Hardy, R., Butterworth, S., Okell, L., Wadsworth, M., Cooper, C., & Aihie Sayer, A. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.7.702 · Cited by 146
Effect of Physical Activity on Frailty: Secondary Analysis of a Randomized Controlled Trial
Trombetti, A., Hars, M., Hsu, F.-C., Reid, K. F., Church, T. S., Gill, T. M., King, A. C., Liu, C. K., Manini, T. M., McDermott, M. M., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m16-2011 · Cited by 115
Self-citationScott, D. W., & Patel, R. P. (2013) · Glycobiology · doi:10.1093/glycob/cwt014 · Cited by 103
Chambers, E. S., Vukmanovic-Stejic, M., Shih, B. B., Trahair, H., Subramanian, P., Devine, O. P., Glanville, J., Gilroy, D., Rustin, M. H. A., Freeman, T. C., et al. (2021) · Nature Aging · doi:10.1038/s43587-020-00010-6 · Cited by 96
Zhang, L., Zhao, J., Mu, X., McGowan, S. J., Angelini, L., O'Kelly, R. D., Yousefzadeh, M. J., Sakamoto, A., Aversa, Z., LeBrasseur, N. K., et al. (2021) · Aging Cell · doi:10.1111/acel.13486 · Cited by 89
Self-citationPhysical performance and longevity in aged rats
Carter, C. S., Sonntag, W. E., Onder, G., & Pahor, M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.b193 · Cited by 68
Self-citationIdentification of Sarcopenia Components That Discriminate Slow Walking Speed: A Pooled Data Analysis
Manini, T. M., Patel, S. M., Newman, A. B., Travison, T. G., Kiel, D. P., Shardell, M. D., Pencina, K. M., Wilson, K. E., Kelly, T. L., Massaro, J. M., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16524 · Cited by 60
Self-citation
Cited by
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
Granic, A., Suetterlin, K., Shavlakadze, T., Grounds, M. D., & Sayer, A. A. (2023) · Clinical Science · doi:10.1042/cs20230319 · Cited by 136
Dowling, P., Gargan, S., Swandulla, D., & Ohlendieck, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032415 · Cited by 109
Biomarkers of cellular senescence and risk of death in humans
St. Sauver, J. L., Weston, S. A., Atkinson, E. J., Mc Gree, M. E., Mielke, M. M., White, T. A., Heeren, A. A., Olson, J. E., Rocca, W. A., Palmer, A. K., et al. (2023) · Aging Cell · doi:10.1111/acel.14006 · Cited by 86
Self-citationMillar, C. L., Iloputaife, I., Baldyga, K., Norling, A. M., Boulougoura, A., Vichos, T., Tchkonia, T., Deisinger, A., Pirtskhalava, T., Kirkland, J. L., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105612 · Cited by 88
Metadata
- Authors
- Fielding, R. A., Atkinson, E. J., Aversa, Z., White, T. A., Heeren, A. A., Achenbach, S. J., Mielke, M. M., Cummings, S. R., Pahor, M., Leeuwenburgh, C., & LeBrasseur, N. K.
- Affiliations
- Tufts University (US)
- Mayo Clinic (US)
- Wake Forest University Health Sciences (US)
- University of California, San Francisco (US)
- University of Florida (US)
- Corresponding author
- LeBrasseur, Nathan K.
- ORCID
- Venue
- GeroScience
- Published
- 2022-11-11
- Volume
- 44
- Issue
- 6
- Pages
- 2757-2770
- ISSN
- 2152-4041 (ISSN-L)
- 2509-2715
- 2509-2723
- PMC
- PMC9768064
- OpenAlex
- W4308767256
- Cited by
- 75
- References
- 35
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 21 · 2023: 20
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- GeroScience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01 AG62413, R01 AG55529, R56 AG060907, P30 AG031679, P30 AG028740)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- cellular senescence, senescence-associated secretory phenotype, physical function, older adults, mobility impairment, muscle strength, grip strength, walking speed, balance, activin A, ICAM-1, MMP-7, VEGF-A, eotaxin, biomarkers, life studies
- MeSH terms
- Aged, Cross-Sectional Studies, Female, Humans, Life Style, Male, Biomarkers, Cellular Senescence, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.